GeneDx Holdings Corp. ($WGS)
Filing Information
| Accession Number | 0001944119-26-000021 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 30, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
41,318
Total Value
$557,051.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 26, 2026 | Exercise/Conversion | 16,250 | $0.00 | $0.00 | 43,398 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 26, 2026 | Sale | 2,485 | $61.29 | $152,307.89 | 40,913 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 26, 2026 | Sale | 961 | $62.33 | $59,900.96 | 39,952 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 26, 2026 | Sale | 2,520 | $63.28 | $159,463.33 | 37,432 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 26, 2026 | Sale | 995 | $64.60 | $64,276.30 | 36,437 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 26, 2026 | Sale | 1,857 | $65.21 | $121,102.96 | 34,580 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Restricted Stock Unit | Derivative | Mar 26, 2026 | Exercise/Conversion | 16,250 | $0.00 | $0.00 | 32,500 | Direct | โ | View Details |